The abnormalities in the coagulation factory in patients with essential hypertension and relationship between the coagulation abnormalities and end organ damage

dc.contributor.authorÇelebi, Harika
dc.contributor.authorKaraca, Ilgın
dc.contributor.authorİlkay, Erdoǧan
dc.contributor.authorTamer, Ali
dc.contributor.authorKoç, Zuhal
dc.date.accessioned2021-06-23T18:54:28Z
dc.date.available2021-06-23T18:54:28Z
dc.date.issued2005
dc.departmentBAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractHypertension is one of the important health problems in the world due to its high incidence and the fact that it causes mortality and morbidity. Mortality and morbidity in hypertensive patients are caused by damage of the target organ. Hypertensive patients are found to have impairments in coagulation mechanism in comparison to normotensive people. The relation between coagulation abnormalities in hypertensives and damage of the target organ is debatable. In this study we investigated coagulation abnormalities in hypertensive patients and the relation between the possible abnormality and target organ damage. Prothrombin time, partial thromboplastin time, fibrinogen, D-dimer and antithrombin III were measured in 50 essential hypertension patients and 50 normotensive controls. Target organ damage was assessed by clinical evaluation and laboratory tests including measurement of creatine clearance, proteinuria, ophthalmoscopy, electrocardiography, echocardiography, and ultrasound examination of major arteries. Plasma fibrinogen and D-dimer levels were significantly greater in hypertensives than normotensive controls. Antitrombin III level was significantly lower in hypertensives than controls. Hypertensive patients had greater body mass index and triglyceride and LDL cholesterol levels and lower HDL cholesterol than controls. The difference in terms of impairment of coagulation parameters was not statistically significant between hypertensive cases with target organ damage and hypertensive cases without target organ damage. Elevated plasma levels of fibrinogen, D-dimer and lower level of AT III in patients with essential hypertension may contribute to the development of atherosclerotic disease. Copyright © Hellenic Society of Haematology.en_US
dc.identifier.endpage254en_US
dc.identifier.issn1108-2682
dc.identifier.issue2en_US
dc.identifier.scopus2-s2.0-21744439182en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage249en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12491/4447
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-21744439182&partnerID=40&md5=d8e4f3ceeeb50153c817bcb81b39730a
dc.identifier.volume8en_US
dc.indekslendigikaynakScopusen_US
dc.institutionauthorÇelebi, Harika
dc.institutionauthorTamer, Ali
dc.language.isoenen_US
dc.relation.ispartofHAEMAen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAntithrombin IIIen_US
dc.subjectD-dimeren_US
dc.subjectFibrinogenen_US
dc.subjectHypertensionen_US
dc.subjectTarget Organ Damageen_US
dc.titleThe abnormalities in the coagulation factory in patients with essential hypertension and relationship between the coagulation abnormalities and end organ damageen_US
dc.typeArticleen_US

Dosyalar